In 1981, the DEA submitted a recognize of intention to place ketamine in Program III in the Managed Substances Act, but evidence of genuine abuse was scarce and didn't aid the designation. As a result of protection issues, the drug will only be readily available via a restricted distribution system https://ketalinic.com/about-us/